Yi Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 9
- Glycosylation and Glycoproteins Research 8
- Oncology 68
- Cancer Cells and Metastasis 23
- Peptidase Inhibition and Analysis 11
- Co-authors
- Jialin Zheng (2 shared papers)Xiaohuan Xia (2 shared papers)Shengyang Fu (1 shared paper)Yuichi Sugiyama (1 shared paper)Kazuya Maeda (1 shared paper)Satoshi Kitamura (1 shared paper)Huaner Ni (1 shared paper)Zhiyan Wang (1 shared paper)
- Journals
- Carbohydrate Polymers (6 papers)PLoS ONE (4 papers)Acta Pharmacologica Sinica (4 papers)Food Science and Human Wellness (3 papers)Frontiers in Pharmacology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yi Wang
260 papers receiving 6.4k citations
Yi Wang's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.1k
- Oncology 1.1k
- Molecular Biology 2.9k
- Biochemistry 177
- Cell Biology 449
Countries citing papers authored by Yi Wang
This map shows the geographic impact of Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Wang more than expected).
Fields of papers citing papers by Yi Wang
This network shows the impact of papers produced by Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Wang. The network helps show where Yi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosome engineering: Current progress in cargo loading and targeted delivery Hit paper breakdown → | 2020 | 349 |
| 2 | 2019 | 336 | |
| 3 | 2008 | 301 | |
| 4 | Engineering polyphenols with biological functions via polyphenol-protein interactions as additives for functional foods Hit paper breakdown → | 2021 | 248 |
| 5 | 2009 | 157 | |
| 6 | 2009 | 147 | |
| 7 | 2006 | 143 | |
| 8 | 2018 | 121 | |
| 9 | 2019 | 106 | |
| 10 | 2002 | 100 | |
| 11 | 2010 | 100 | |
| 12 | 2016 | 99 | |
| 13 | 2009 | 98 | |
| 14 | 2013 | 96 | |
| 15 | 2009 | 96 | |
| 16 | 2013 | 91 | |
| 17 | 2012 | 90 | |
| 18 | 2014 | 80 | |
| 19 | 2013 | 79 | |
| 20 | 2011 | 74 |
About Yi Wang
Yi Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Immunology, having authored 273 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (23 papers), Cancer, Hypoxia, and Metabolism (15 papers), Proteoglycans and glycosaminoglycans research (11 papers), Peptidase Inhibition and Analysis (11 papers), Cancer-related molecular mechanisms research (9 papers), Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (9 papers) and Glycosylation and Glycoproteins Research (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.1k citations), Molecular Biology (2.9k citations), Biochemistry (177 citations) and Cell Biology (449 citations). Yi Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jialin Zheng, Xiaohuan Xia, Shengyang Fu, Yuichi Sugiyama, Kazuya Maeda, Satoshi Kitamura, Huaner Ni, Zhiyan Wang, Jumo Zhu and Lili Zhang. Their work appears in journals such as Carbohydrate Polymers, PLoS ONE, Acta Pharmacologica Sinica, Food Science and Human Wellness and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.